This draft Commission Implementing Decision repeals the postponement of the expiry date of the approval of cypermethrin for use in biocidal products of product type (PT) 8. On 24 November 2023, an application was submitted in accordance with Article 13(1) of Regulation (EU) No 528/2012 for the renewal of the approval of cypermethrin for use in biocidal products of PT8. On 21 May 2025, the applicant has informed the Commission that they withdrew their support for cypermethrin for PT8. Consequently, a draft Decision is being prepared to not renew the approval of cypermethrin for PT8. Further to that Decision, it is necessary to repeal the postponement of the expiry date of the approval of cypermethrin for PT8. The present draft Decision therefore intends to repeal Decision (EU) 2025/362 postponing the expiry date of the approval of cypermethrin for PT8